Roche Promotes Lung Cancer Therapies, ArQule

Roche drugs point to personalized lung cancer care

(Reuters) - Roche's experimental drug MetMab and its established product Tarceva showed impressive results in lung cancer trials on Saturday, highlighting how treating the disease is becoming much more focused.


Cancer experts meeting Milan said personalized treatment, first seen in breast cancer, was now emerging as a major theme in lung cancer. The shift could reduce the use of less targeted drugs, including Roche's own top-selling Avastin.

Monday's BioPharma List for August 9th

Top Pharmaceuticals for Monday August 9th

1. K-V Pharmaceuticals This one is slightly unpredictable (NYSE:KV.A) at 1.46 up +0.17 a 13.17% gain after having a 20.6% increase last week.

2. Roche Holdings RHHBF; F denotes a foreign stock trading on Nasdaq this quote is from last week as this stock trades based on a foreign market. Last week up 10.50 at 142.00 a 10.50% gain. The stock has been down as of late but I predict that things could change in the near future for the better.

Their US Based stock RHHBY was flat today. (RHHBY)